Santosh Kesari

Dr. Kesari is currently the Director of Neuro-oncology, Professor of Neurosciences, and Chairman of the Department of Translational Neuro-oncology and Neuro-therapeutics at the John Wayne Cancer Institute. From 2009 through 2015, he was the Director of the Neuro-Oncology Program, Director of the Neurotoxicity Treatment Center, and Director of the Translational Neuro-Oncology Laboratories at Moores Cancer Center and a Professor of Neurosciences at the UC San Diego School of Medicine. Prior to coming to UC San Diego in 2009, he was an Assistant Professor of Neurology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston from 2003 to 2009.

Dr. Kesari was determined to be among the top 1% neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd., which reports its findings as the U.S. News & World Report Top Doctor list. He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 200 scientific publications and is the inventor on several patents and patent applications.

Dr. Kesari is board certified in Medical Oncology and Neurology. He completed his residency at Massachusetts General Hospital/Brigham and Women’s Hospital in Boston and his fellowship at the Dana-Farber Cancer Institute in Boston. He earned a Ph.D. degree in molecular biology and a medical degree from the University of Pennsylvania School of Medicine. He is a member of the Society of Neuro-Oncology, American Society of Clinical Oncology, Indian Society of Neuro-Oncology, and American Academy of Neurology.